These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9141655)

  • 1. Molecular mechanisms of azole resistance in fungi.
    Joseph-Horne T; Hollomon DW
    FEMS Microbiol Lett; 1997 Apr; 149(2):141-9. PubMed ID: 9141655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    Nishimoto AT; Sharma C; Rogers PD
    J Antimicrob Chemother; 2020 Feb; 75(2):257-270. PubMed ID: 31603213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RTA2, a novel gene involved in azole resistance in Candida albicans.
    Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
    Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular and biochemical mechanisms of drug resistance in fungi].
    Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(4):199-208. PubMed ID: 10536306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K; Strzelczyk JK; Owczarek A; Cuber P; Ślemp-Migiel A; Wiczkowski A
    Acta Biochim Pol; 2015; 62(2):247-51. PubMed ID: 25901298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
    Siikala E; Rautemaa R; Richardson M; Saxen H; Bowyer P; Sanglard D
    J Antimicrob Chemother; 2010 Dec; 65(12):2505-13. PubMed ID: 20876623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic studies on the mode of action of azole antifungal agents.
    Kelly SL; Rowe J; Watson PF
    Biochem Soc Trans; 1991 Aug; 19(3):796-8. PubMed ID: 1783219
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
    Li X; Cai Q; Mei H; Zhou X; Shen Y; Li D; Liu W
    J Antimicrob Chemother; 2015 Jul; 70(7):1993-2003. PubMed ID: 25825380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2.
    Bruno VM; Mitchell AP
    Mol Microbiol; 2005 Apr; 56(2):559-73. PubMed ID: 15813744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
    Holmes AR; Tsao S; Ong SW; Lamping E; Niimi K; Monk BC; Niimi M; Kaneko A; Holland BR; Schmid J; Cannon RD
    Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.
    Xiang MJ; Liu JY; Ni PH; Wang S; Shi C; Wei B; Ni YX; Ge HL
    FEMS Yeast Res; 2013 Jun; 13(4):386-93. PubMed ID: 23480635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of azole resistance in Candida albicans clinical isolates.
    Hooshdaran MZ; Barker KS; Hilliard GM; Kusch H; Morschhäuser J; Rogers PD
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2733-5. PubMed ID: 15215138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.